← back to search

Ramesh Kandimalla

Kakatiya University · IN
Area of research
Infectious Diseases · Physiology
Research interest
Research interests include Alzheimer's disease research and treatments, SARS-CoV-2 and COVID-19 Research, Mitochondrial Function and Pathology, and COVID-19 Clinical Research Studies.
h-index
46
citations
11,134
works
157
NIH funding
primary concept
email

Recent publications

Depressive Symptoms and Amyloid Pathology
JAMA Psychiatry 2025cited by 19position: middledoi
Autophagy and mitophagy as potential therapeutic targets in diabetic heart condition: Harnessing the power of nanotheranostics
Asian Journal of Pharmaceutical Sciences 2024cited by 7position: lastdoi
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
JAMA Neurology 2022cited by 280position: middledoi
Carbon-Based Nanomaterials: Promising Antiviral Agents to Combat COVID-19 in the Microbial-Resistant Era
ACS Nano 2021cited by 179position: middledoi
A unique view of SARS-CoV-2 through the lens of ORF8 protein
Computers in Biology and Medicine 2021cited by 76position: middledoi
Autoimmunity roots of the thrombotic events after COVID-19 vaccination
Autoimmunity Reviews 2021cited by 59position: middledoi
Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
International Journal of Biological Macromolecules 2021cited by 57position: middledoi
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
Biomolecules 2021cited by 41position: middledoi
Podophyllum hexandrum and its active constituents: Novel radioprotectants
Biomedicine & Pharmacotherapy 2021cited by 38position: middledoi
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function
International Journal of Biological Macromolecules 2021cited by 27position: middledoi
The structural basis of accelerated host cell entry by SARS‐CoV‐2†
FEBS Journal 2020cited by 176position: middledoi
SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020cited by 94position: lastdoi
Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics
Molecular Neurobiology 2020cited by 50position: firstdoi
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
Molecules 2020cited by 34position: middledoi
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Alzheimer s & Dementia 2018cited by 89position: middledoi
Liquid Crystals: A Novel Approach for Cancer Detection and Treatment
Cancers 2018cited by 41position: middledoi
Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease
Human Molecular Genetics 2016cited by 180position: middledoi
Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer’s disease
Human Molecular Genetics 2016cited by 176position: firstdoi
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia
JAMA 2015cited by 1,610position: middledoi
Understanding Aspects of Aluminum Exposure in <scp>A</scp>lzheimer's Disease Development
Brain Pathology 2015cited by 173position: firstdoi
Antiangiogenic effects of a novel synthetic curcumin analogue in pancreatic cancer
Cancer Letters 2014cited by 85position: middledoi
CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Current Alzheimer Research 2014cited by 33position: firstdoi
Imaging and curcumin delivery in pancreatic cancer cell lines using PEGylated α-Gd<sub>2</sub>(MoO<sub>4</sub>)<sub>3</sub>mesoporous particles
Dalton Transactions 2013cited by 36position: middledoi
PEGylated α-Gd<sub>2</sub>(MoO<sub>4</sub>)<sub>3</sub> Mesoporous Flowers: Synthesis, Characterization, and Biological Application
Crystal Growth & Design 2013cited by 34position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2020–2021) · 6 papers (2020–2021) · 6 papers (2020–2021) · 6 papers (2020–2021)Samendra P. Sherchan · University of Arizona6 papers (2020–2021)Parise Adadi · Ural Federal University6 papers (2020–2021) · 6 papers (2020–2021)Vladimir N. Uversky · Hospital for Sick Children6 papers (2020–2021)Giorgio Palù · University of Padua6 papers (2020–2021) · 6 papers (2020–2021) · 6 papers (2020–2021) · 6 papers (2020–2021) · 5 papers (2020–2021)Gajendra Kumar Azad · Hebrew University of Jerusalem5 papers (2020–2021)P. Hemachandra Reddy · Texas Tech University5 papers (2016–2020)Gaurav Chauhan · University of Massachusetts Chan Medical School5 papers (2020–2021)Adam Brufsky · UPMC Hillman Cancer Center4 papers (2020–2021)Damiano Pizzol · University of Padua4 papers (2020–2021) · 4 papers (2021–2021)Amos Lal · University of Massachusetts Chan Medical School4 papers (2021–2021)